anti-CD33 CAR T cells
Term · Oncology and biomedicine · MLC-T-ONC-010340
A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the CD33 antigen, with potential immunomodulating and antineoplastic activities. Upon administration, anti-CD33 CAR T cells specifically recognize and kill CD33-expressing tumor cells. CD33 is expressed on normal non-pluripotent hematopoietic stem cells and is overexpressed on myeloid leukemia cells.
| Identifier | MLC-T-ONC-010340 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-CD33 CAR-T cells; CD33-CAR T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010340",
"term": "anti-CD33 CAR T cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the CD33 antigen, with potential immunomodulating and antineoplastic activities. Upon administration, anti-CD33 CAR T cells specifically recognize and kill CD33-expressing tumor cells. CD33 is expressed on normal non-pluripotent hematopoietic stem cells and is overexpressed on myeloid leukemia cells.",
"synonyms": [
"anti-CD33 CAR-T cells",
"CD33-CAR T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-cd33-car-t-cells/"
}
Record 1,427 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.